$FHTX - Foghorn Therapeutics CEO Tells Us How He’s Using Biology To Fight Cancer

$FHTX - Foghorn Therapeutics CEO Shares Timeless Advice &
Tells Us How He’s Using Biology To Fight Cancer Guest: Adrian
Gottschalk, President & CEO Foghorn Therapeutics $FHTX BIO:
Adrian is president and chief executive officer of Foghorn
Therapeutics. An experienced leader in biotech, Adrian is
interested in solving complex issues at the intersection of
science, medicine, and business on a global scale to help people
and families dealing with diseases. Prior to joining Foghorn,
Adrian spent 13 years at Biogen, where he was most recently a
senior vice president and the neurodegeneration therapeutic area
head. In this role, he was responsible for the late-stage
development and commercialization of medicines for Alzheimer’s
disease, Parkinson’s disease, and amyotrophic lateral sclerosis
(ALS). During his time at Biogen, Adrian held additional roles of
increasing responsibility ranging from head of corporate
strategy, head of global commercial strategy, head of Japan, and
head of the Japan, Australia and Emerging Markets geographies. He
has also worked as a consultant for Price Waterhouse in Dallas,
Texas. He holds a BS in biochemistry from Texas A&M
University and received his MBA from the Sloan School of
Management at MIT. He also holds an ScM degree from the joint
Harvard Medical School / MIT Biomedical Enterprise Program, where
his graduate work was focused on evaluating the costs and
benefits of the Prescription Drug User Fee Acts and improving the
efficiency of the drug development process.